Ozempic Wars | The Hundred-Year Duel | 1
Nov 19, 2025•35 min•Season 122Ep. 1
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
When pharmaceutical giant Novo Nordisk developed a new medication for type 2 diabetes, they noticed that a welcome side effect was a small amount of weight loss. They had no idea that their new diabetes medication was about to become a multibillion-dollar weight loss drug. But they had no sooner launched this game-changing drug, then competitors swooped in to knock Novo Nordisk off its throne.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
For the best experience, listen in Metacast app for iOS or Android